Skip to main content

References: Chronic Urticaria

pdfASCIA HP References: Chronic Urticaria306.2 KB

Akoglu, G., Atakan, N., Cakır, B., Kalayci, O., & Hayran, M. (2012). Effects of low pseudoallergen diet on urticarial activity and leukotriene levels in chronic urticaria. Arch Dermatol Res, 304(4), 257-262.

Anuradha, P., Maiti, R., Jyothirmai, J., Mujeebuddin, O. & Anuradha, M.  (2010). Loratadine versus levocetirizine in chronic idiopathic urticaria: a comparative study of the efficacy and safety. Indian J Pharacol, 42(1), 12-16.

Arkwright, P.D. (2009). Anti-CD20 or anti-IgE therapy for severe chronic autoimmune urticaria. J Allergy Clin Immunol, 123(2), 510-511.

Asero, R. (2007). Chronic unremitting urticaria: is the use of antihistamines above the licensed dose effective. A preliminary study of cetirizine at licensed and above-licensed doses. Clin Exp Dermatol, 32(1), 34-8.

Asero, R., Tedeschi, A., & Cugno, M. (2010). Heparin and Tranexamic Acid therapy may be effective in treatment-resistant chronic urticaria with elevated d-dimer: a pilot study. Int Arch Allergy Immunol, 152(4), 384-389.

Asero, R., & Tedeschi, A.  (2010). Usefulness of a short course of oral prednisone in antihistamine-resistant chronic urticaria: a retrospective analysis. J Investig Allergol Clin Immunol, 20, 386-90.

Asero R, Tedeschi A, & Cugno M. (2013). Treatment of refractory chronic urticaria: current and future therapeutic options. Am J Clin Dermatol, 14(6), 481-488.

Augustin, M., & Ehrle S. (2009). Safety and efficacy of desloratadine in chronic idiopathic urticaria in clinical practice: an observational study of 9246 patients. J Eur Acad Dermatol Venereol, 23(3), 292-299.

Aversano, M., Caiazzo, P., Iorio, G., Ponticiello, L., Laganá, B., & Leccese, F. (2005). Improvement of chronic idiopathic urticaria with L-thyroxine: a new TSH role in immune response? Allergy, 60(4), 89-93.

Babu, K.S., Arshad, S.H., & Holgate, S.T. (2001). Omalizumab, a novel anti-IgE therapy in allergic disorders. Expert Opin Biol Ther, 1(6), 1049-1058.

Bagenstose, S.E., Levin, L., & Bernstein, J.A. (2004). The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results. J Allergy Clin Immunol, 113(1),134-40.

Baiardini, I., Braido, F., Bindslev-Jensen, C., Bousquet, P.J., Brzoza, Z., Canonica, G.W., … Maurer, M. (2011). Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA2LEN taskforce position paper. Allergy, 66, 840-844.

Banan, P., Butler, G., & Wu, J. (2014). Retrospective chart review in a cohort of patients with urticarial dermatitis. Aust J Derm, 55(2), 137-139.

Baumgart, K., & Mullins, R. (2000). Use of hydroxychloroquine in refractory urticaria. J Allergy Clin Immunol, 105(1), S268-S269.

Beck, L.A., Marcotte, G.V., MacGlashan, D., Togias, A., & Saini, S. (2004). Omalizumab-induced reductions in mast cell Fc epsilon RI expression and function. J Allergy Clin Immunol, 114(3), 527-530.

Ben-Shoshan, M., Blinderman, I., & Raz, A. (2013). Psychosocial factors and chronic spontaneous urticaria: a systematic review. Allergy, 68(2), 31-41.

Bernstein, J.A, Lang, D.M., Khan, D.A., Craig, T., Dreyfus, D., Hsieh, F., … Wallace, D. (2014). The diagnosis and management of acute and chronic urticaria: 2014 update. J Allergy Clin Immunol, 133(5), 1270-1277.

Bernstein, J.A., Kavati, A., Tharp, M.D., Ortiz, B., MacDonald, K., Denhaerynck, K. & Abraham, I.L. (2018). Effectiveness of omalizumab in adolescent and adult patients with chronic idiopathic/spontaneous urticaria: a systemic review of ‘real-world’ evidence. Expert Opinion on Biological Therapy, 18(4), 425-448.

Berth-Jones, J., Hutchinson, P.E., Wicks, A.C., & Mitchell, V.E. (1988). Chronic urticaria with angio-oedema controlled by warfarin. BMJ. 297(6660), 1382-1383.

Bingham, C.O., Jones, P.E., Gober, L.M., Eckman, J.A., Sterba, P.M., & Saini SS. (2008). Targeted B-cell Depletion using Rituximab (Anti-CD20) in Recalcitrant Autoimmune Urticaria. J Allergy Clin Immunol, 121(2), S172.

Bleehan, S.S., Thomas, S.E., Greaves, M.W., Newton, J., Kennedy, C.T.C., Hindley, F., … Howland, K. (1987). Cimetidine and chlorpheniramine in the treatment of chronic idiopathic urticaria: a multi-centre randomized double-blind study.  Br J Dermatol, 117(1), 81-88.

Boonpiyathad, S., Fuengthong, R., & Sangasapaviriya, A. (2013). Effect of hydroxychloroquine treatment in the patients with anti-histamine refractory chronic spontaneous urticaria, randomised controlled trial. Allergy, 68(97), 62-62. 

Boonpiyathad, T., & Sangasapaviliya, A. (2017). Hydroxychloroquine in the treatment of anti-histamine refractory chronic spontaneous urticaria, randomized single-blinded placebo-controlled trial and an open label comparison study. Eur Ann Allergy Clin Immunol, 49(5), 220-224.

Boubouka, C.D., Charissi, C., Kouimintzis, D., Kalogeromitros, D., Stavropoulos, P.G., & Katsarou, A. (2011). Treatment of autoimmune urticaria with low-dose cyclosporin A: A one-year follow-up. Acta dermato-venereologica, 91(1), 50-4.

Breneman, D.L. (1996). Cetirizine versus hydroxyzine and placebo in chronic idiopathic urticaria. Ann Pharmacother, 30(10), 1075-1079.

Broder, M.S., Raimundo, K., Antonova, E., & Chang, E. (2015). Resource Use and Costs in an Insured Population of Patients with Chronic Idiopathic/Spontaneous Urticaria. Am J Clin Dermatol, 16(4), 313-321.

Brown, N.A, & Carter, J.D. (2007). Urticarial Vasculitis. Curr Rheumatol, 9(4), 312-319.

Brüske, I., Standl, M., Weidinger, S., Klümper, C., Hoffmann, B., Schaaf, B., Herbarth I., … Heinrich, J. (2013). Epidemiology of urticaria in infants and young children in Germany – Results from the German LISAplus and GINIplus Birth Cohort Studies. Ped Allergy Immunol. 25(1).

Bunselmeyer, B., Laubach, H.J., Schiller, M., Stanke, M., Luger, T.A., & Brehler, R. (2009). Incremental build-up food challenge - a new diagnostic approach to evaluate pseudoallergic reactions in chronic urticaria: a pilot study: stepwise food challenge in chronic urticaria. Clin Exp Allergy, 39(1)116-26.

Caffarelli, C., Cuomo B, Cardinale, F., Barberi, S., Dascola, C.P., Aqostinis, F., & Bernardini, R. (2013) Aetiological factors associated with chronic urticaria in children: a systematic review. Acta Derm Venereol, 93(3), 268-272.

Cassano, N., D’Argento, V., Filotico, R., & Vena, G. (2005). Low dose dapsone in chronic idiopathic urticaria: Preliminary results of an open study. Acta Derm Venereol, 85(3), 254–255.

Chakravarty, S.D., Yee, A.F., & Paget, S.A. (2011). Rituximab successfully treats refractory chronic autoimmune urticaria caused by IgE receptor autoantibodies. J Allergy Clin Immunol, 128(6), 1354-1355.

Chansakulporn S, Pongpreuksa S, Sangacharoenkit P, Pacharn, P., Visitsunthorn, N. Vichyanond,  Jirapongsananuruk, O. (2014). The natural history of chronic urticaria in childhood: a prospective study. J Am Acad Dermatol, 71(4), 663-668.

Chua, S.L., & Gibbs, S. (2005). Chronic urticaria responding to subcutaneous heparin sodium. Br J Dermatol, 153(1), 216-217.

Church, M.K., Weller, C., Stock, P., & Maurer, M. (2011). Chronic spontaenous urticaria in children: Itching for insight. Paediatr Allergy Immunol, 22(1), 1-8.

Clarke, J.J., Secrest, A.M., Hull, C.M., Eliason, M.J. Leiferman, K.M., Gleich, G.J. & Powell, D.L. (2016). The effect of omalizumab dosing and frequency in chronic idiopathic urticaria: Retrospective chart review. J Am Acad Dermatol, 74(6), 1274-1276.

Curto-Baredo, l., Spertino, J., Figueras-Nart, I., Expósito‐Serrano, V., Guilabert, A., Melé‐Ninot, G., … Giménez‐Arnau, A. (2018). Omalizumab updosing allows disease control in refractory patients with chronic spontaneous urticaria. Br J Dermatol, 179(1), 210-212.

Di Lorenzo, G., Pacor, M.L., Mansueto, P., Pellitteri, E., Lo Bianco, C., Ditta, V., Martinelli, N., & Rini, B. (2004). Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria. J Allergy Clin Immunol, 114(3), 619-625.

Diaz-Angulo, S., Lopez-Hoyos, M., Munoz Casho P, Fernandez, M., Lopez-Escobar, M., Rodriguez, F., & Gonzalez-Lopez, M.A. (2016). Prevalence of thyroid autoimmunity in Spanish patients with chronic idiopathic urticaria: a case-control study involving 343 subjects. J Eur Acad Dermatol Venereol, 30, 692-693.

Ditto, A. M., (2007). Hydroxychloroquine in the treatment of 12 patients with severe chronic idiopathic urticaria; a case series. J Allergy Clin Immunol, 119(1).

Doeglas, H.M., (1977). Dietary treatment of patients with chronic urticaria and intolerance to aspirin and food additives. Dermatologica, 54(5), 308-310.

Doshi, D.R., & Weinberger, M.M. (2009). Experience with cyclosporine in children with chronic idiopathic urticarial. Pediatr Dermatol, 26, 409-13.

Duvall, L.A., Boackle, R.J., & King, R.G., (1986). Warfarin sodium therapy for chronic urticaria and angioedema. South Med J. 79(3), 389.

Eapen, A., & Kloepfer, K.M., (2018). Serum sickness-like reaction in a pediatric patient using omalizumab for chronic spontaneous urticaria. Peadr All Immunol, 29(4), 449-450.

Eastman, J., Wilde, N., & Jerath, M.R. (2014). Outcomes of Chronic Urticaria Patients Treated with Hydroxychloroquine. J Allergy Clin Immunol, 133(2), AB119.

Egeberg, A., Kofoed, K., Gislason, G.H., Vestergaard, C., & Thyssen, J.P. (2017). Cardiovascular risk is not increased in patients with chronic spontaneous urticaria: A retrospective population-based cohort study. Acta Derm Venereol, 97, 261-262.

Ehlers, I. Niggemann, B., Binder, C., & Zuberbier, T. (1998). Role of nonallergic hypersensitivity reactions in children with chronic urticaria. Allergy, 53(11), 1074-1077.

Engin, B., & Ozdemir, M. (2008). Prospective randomised non-blinded clinical trial on the use of dapsone plus antihistamine vs. antihistamine in patients with chronic idiopathic urticaria. JEADV, 22, 481–486.

European Medicines Agency. Xolair summary of product characteristics. human/000606/WC500057298.pdf.

Erbagci, Z. (2002). The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled crossover clinical study.  J Allergy Clin Immunol, 110, 484-488.

Fagiolo, U., Cancian, M., Bertollo, L., Peserico, A., & Amadori, A. (1999). Inhibitory effect of heparin on skin reactivity to autologous serum in chronic idiopathic urticaria. J Allergy Clin Immunol, 103(6), 1143-1147.

Finn, A. F., Allen, P., Kaplan, M.D., Fretwell, R.F., Qu, R & Long, J. (1999). A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol, 104(5), 1071-1078.

Gach, J.E., Sabroe, R.A., Greaves, M.W., & Black, A.K. (2001). Methotrexate-responsive chronic idiopathic urticaria: a report of two cases. Br J Dermatol, 145, 340-343.

Gaig, P., Olona, M., Munoz Lejarazu, D., Caballero, M.T., Dominquez, F.J., Eschechipia, S., … Ferrer, M. (2004). Epidemiology of urticaria in Spain. J Investig Allergol Clin Immunol, 14(3), 214-220.

Garg, G., & Thami, G.P. (2007). Comparative efficacy of cetirizine and levocetirizine in chronic idiopathic urticaria.  J Dermatolog Treat, 18(1), 23-24.

Godse, K.V. (2006). Oral monelukast monotherapy is ineffective in chronic idiopathic urticaria: a comparison with oral cetirizine. Indian J Dermatol Venereol Leprol, 72 (4), 312-314.

Goh, C.L., Wong, W.K., & Lim J. (1991). Cetirizine vs placebo in chronic idiopathic urticaria: a double blind randomized cross-over study. Ann Acad Med Singapore, 20(3), 328-30.

Goldsobel, A.B., Rohr, A.S., Siegel, S.C., Spector, S.L. Katz, R.M., Rachelefsky, G.S. …. Barr, R.J. (1986). Efficacy of doxepin in the treatment of chronic idiopathic urticarial.  J Allergy Clin Immunol. 78(5), 867-873.

Grant, J.A., Bernstein, D.I., Buckley, C.E., Chu, T., Fox, R.W., Rocklin, R.E. … Karpenter, K.M. (1998). Double-blind comparison of terfenadine, chlorpheniramine and placebo in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol, 81(3), 574-579.

Grattan, C.E., Wallington, T.B., Warin, R.P., Kennedy, C.T.C., & Bradfield, J.W. (1986). A serological mediator in chronic idiopathic urticaria- a clinical, immunological and histological evaluation. Br J Dermatol, 114(5), 583-590.

Grattan, C.E., O’Donnell, B.F., Francis, D.M., Nimi, N., Barlow, R.J., Seed, PT., … Greaves, M.W. (2000). Randomized double blind study of cyclosporin in chronic ‘idiopathic’ urticaria. Br J Dermatol, 143(2), 365-372.

Grattan, C.E., Dawn, G., Gibbs, S., & Francis, D.M. (2003). Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity. Clin Exp Allergy, 33(3), 337-341.

Gray, P.E., Mehr, S., Katelaris, C.H., Wainstein, B.K., Star, A., Campbell, D., … Ziegler, J.B. (2013). Salicylate elimination diets in children: is food restriction supported by the evidence? Med J Aust, 198(11), 600-602.

Greaves, M.W. (2000). Chronic urticaria in childhood. Allergy, 55(4), 309-320.

Green, J.P., & Maasyani, S. (1977). Tricyclic antidepressant drugs block histamine H2 receptors in brain. (1977). Nature, 269(5624), 163-165.

Groffik, A., Mitzel-Kaoukhov, H., Magerl, M., Maurer, M., & Staubach, P. (2011). Omalizumab-an effective and safe treatment of therapy-resistant chronic spontaneous urticaria. Allergy, 66(2), 303-305.

Guerra, L., Vinceni, C., Marchesi, E., Tosti, A., Pretto, E., Bassi, R., … De Costanza, F. (1994). Loratadine and cetirizine in the treatment of chronic urticaria. J Eur Acad Dermatol Venereol, 3(2), 148-152.

Guida, B., De Martino, C.D., De Martino, S.D., Tritto, G., Patella, V., Trio, R., … D'Agostino L. (2000). Histamine plasma levels and elimination diet in chronic idiopathic urticaria. Eur J Clin Nutr, 54(2), 155-158.

Guillén‐Aguinaga, S., Jáuregui Presa, I., Aguinaga‐Ontoso, E., Guillén‐Grima, F., & Ferrer, M. (2016). Updosing nonsedating antihistamines in patients with chronic spontaneous urticaria: a systematic review and meta‐analysis. Br J Dermatol 175(6), 1153-1165.

Hale,T.W., (2012). Medications and Mothers' Milk. 15th Edition.

Hall, A., & Marshall, G.D. (2013). A Retrospective review of hydroxychloroquine use in patients with chronic idiopathic urticaria (CIU). Ann Allergy Asthma Immunol, 111(5), A18-A19.

Handa, S., Dogra, S., & Kumar, B. (2004). Comparative efficacy of cetirizine and fexofenadine in the treatment of chronic idiopathic urticaria. J Dermatolog Treat, 15(1), 55-57.

Hawro, T., Ohanyan, T., Schoepke, N., Metz, M., Peveling-Oberhag, A., Staubach, P., Maurer, M. & Weller, K. (2018). Comparison and Interpretability of the available Urticaria Activity Scores. Allergy, 73(1), 251-255.

Henz, B.M., & Zuberbier, T. (1998). Most chronic urticaria is food-dependent, and not idiopathic. Exp Dermatol, 7(4), 139-142.

Hide, M., Francis, D.M., Grattan, C.E., Hakimi, J., Kochan, J.P. & Greaves, M.W. (1993). Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med, 328, 1599–1604.

Holgate, S., Casale, T., Wenzel, S., Bousquet, J., Deniz, Y., & Reisner, C. (2005). The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation. J Allergy Clin Immunol, 115(3), 459-465.

Hrabak, T., & Calabria, C.W. (2010). Multiple treatment cycles of high-dose intravenous immunoglobulin for chronic spontaneous urticaria. Ann Allergy Asthma Immunol, 105(3), 245.

Hsu, M.L., & Li, L.F. (2012). Prevalence of food avoidance and food allergy in Chinese patients with chronic urticaria. Br J Dermatol,  166(4), 747-752.

Iribarren, C., Tolstykh, I.V., Miller, M.K., Sobel, E., & Eisner, M.D. (2012). Adult asthma and risk of coronary heart disease, cerebrovascular disease, and heart failure: A prospective study of 2 matched cohorts. Am J Epidem 176(11), 1014-1024.

Iribarren, C., Rahmaoui, A., Long, A.A., Szefler, S.J., Bradley, M.S., Carrigan, G., … Rothman, K.J. (2017). Cardiovascular and cerebrovascular events among patients receiving omalizumab: Results from EXCELS, a prospective cohort study in moderate to severe asthma. J Allergy Clin Immnuol 139(5), 1489-1495.

Jaffer, A.M. (1991). Sulfasalazine in the treatment of corticosteroid-dependent chronic idiopathic urticaria. J Allergy Clin Immunol, 88(6), 964-965.

Jaffer, A.M., & Reid, R.T. (2002). Sulfasalazine in the treatment of chronic urticaria. J Allergy Clin Immunol, 109(1), S127.

Jariwala, S.P., Moday, H., de Asis, M.L., Fodeman, J., Hudes, G., de Vos, G., & Rosenstreich, D. (2009). The Urticaria Severity Score: a sensitive questionnaire/index for monitoring response to therapy in patients with chronic urticarial. Ann Allergy Asthma Immunol, 102(6), 475-482.

Jauregui, I., Ortiz de Frutos, F.J., Ferrer, M., Gimenez-Arnau, A., Sastre, J., Bartra, J., … Valero, A. (2014). Assessment of severity and quality of life in chronic urticaria. Journal of Investigational Allergology and Clin Immunol 24(2), 80-86.

Jirapongsananuruk, O., Pongpreuksa, S., Sangacharoenkit, P., Visitsunthorn, N., & Vichyanond, P. (2010). Identification of the etiologies of chronic urticaria in children: a prospective study of 94 patients. Pediatr Allergy Immunol, 21(3), 508-514.

Juhlin, L. (1981). Recurrent urticaria: clinical investigation of 330 patients. Br J Dermatol, 104(4), 369-381.

Juhlin, L., & Arendt, C. (1988). Treatment of chronic urticaria with cetirizine dihydorchloride a non-sedating antihistaimine. Br J Dermatol, 119(1), 67-72.

Juhlin, L. (1991). Cetirizine in the treatment of chronic urticaria. Clin Ther 13 (1), 81-86.

Kalivas, J., Breneman, D., Tharp, M. Bruce, S., & Bigby, M. (1990). Urticaria: clinical efficacy of cetirizine in comparison with hydroxyzine and placebo. J Allergy Clin Immunol 86(2), 1014-1018.

Kameyoshi, Y., Tanaka, T., Mihara, S., Takahagi, S., Niimi, N., & Hide, M. (2007). Increasing the dose of cetirizine may lead to better control of chronic idiopathic urticaria: an open study of 21 patients. Br J Dermatol, 157(4), 803-804.

Kaplan, A.P. (2002). Clinical practice. Chronic urticaria and angioedema. New England Journal of Medicine, 346(3), 175-179.

Kaplan, A.P. (2004). Chronic urticaria: pathogenesis and treatment. JACI 114(3), 465-474.

Kaplan, A.P., Spector, S.L., Meeves, S., Liao, Y., Verghese, S.t., & Georges, G. (2005). Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind placebo-controlled study.  Ann Allergy Asthma Immunol, 94(6), 662-669.

Kaplan, A.P., Joseph, K., Maykut, R.J., Geba, G.P., & Zeldin, R.K. (2008). Treatment of chronic autoimmune urticaria with omalizumab. J Allergy Clin Immunol, 122(3), 569-573.

Kaplan, A.P. (2012). Treatment of chronic spontaneous urticaria. Allergy Asthma Immunol Res, 4(6), 326-331.

Kaplan, A.P., Ferrer, M., Bernstein, J.A., Antonova, E., Trzaskoma, B., Raimundo, K., … Zazzli, J.L. (2016). Timing and duration of omalizumab response in patients with chronic spontaneous urticaria. J Allergy Clin Immunol, 137(2), 474-481.

Kapp, A., & Pichler, W.J. (2006). Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, pacebo-controlled, parallel, multicenter study. Int J Dermatol 45(4), 469-474.

Kawashima, M., & Harada, M. (2001). Efficacy and safety of fexofenadine HCl in Japanese patients with chronic idiopathic urticaria. Int Arch Allergy Immunol, 124, 343-345.

Kessel, A., Bamberger E., & Toubi, E. (2005). Tacrolimus in the treatment of severe chronic idiopathic urticaria: An open-label prospective study. J Am Acad Dermatol, 52(1), 145–148.

Kessel, A., & Toubi, E. (2010). Cyclosporine-A in severe chronic urticaria: the option for long-term therapy. Allergy, 65(11), 1478-1482.

Khakoo, G., Sofianou-Katsoulis, A., Perkin, M.R., & Lack, G. (2008). Clinical features and natural history of physical urticaria in children. Pediatr Allergy Immunol, 19(4), 363-366.

King, W., McCargar, L., Joneja, J.M., & Barr S.I. (2000). Benefits of a Histamine-Reducing Diet for Some Patients with Chronic Urticaria and Angioedema. Can J Diet Pract Res, 61(1), 24-26.

Kolkhir, P., Church, M.K., Weller, K., Metz, M., Schmetzer, O., & Maurer M. (2017). Autoimmune chronic spontaneous urticaria: What we know and what we do not know. J Allergy Clin Immunol, 139(6), 1772-1781.

Konstantinou, G.N., Papadopoulos, N.G., Tavladaki, T., Tsekoura, T., Tsilimigaki, A., & Grattan, C.E. (2011). Childhood acute urticaria in northern and southern Europe shows a similar epidemiological pattern and significant meteorological influences. Pediatr Allergy Immunol 22, 36-42.

Konstantinou, G.N., Chioti, A.G., & Daniilidis, M. (2016). Self-reported hair loss in patients with chronic spontaneous urticaria treated with omalizumab: an under-reported, transient side effect? Eur Ann Clin Immunol, 48, 205-207.

Kosnik, M., (2011). Add-on montelukast in antihistaimine-resistant chronic idiopathic urticaria. Respir Med, 105 (Suppl1), S84-S88.

Koti, I., Weller, K., Makris, M., Tiligada, E., Psaltopoulou, T., Papageorgiou, C., … Maurer, M. (2013). Disease activity only moderately correlates with quality of life impairment in patients with chronic spontaneous urticaria. Dermatology 226(4), 371-379.

Kulthanan, K., Gritiyarangsan, P., Sitakalin, C., Charuwichitratana, S., Korkij, W., Aunhacachoke, K., … Kullavanijaya P. (2001). Multicenter study of the efficacy and safety of fexofenadine 60mg twice daily in 108 Thai patients with chronic idiopathic urticaria. J Med Assoc Thai, 84(2), 153-159.

Kulthanan, K., Chaweekulrat, P., Komoltri, C., Hunnangkul, S., Tuchinda, P., Chularojanamontri, L., & Maurer, M. (2018). Cyclosporine for Chronic Spontaneous Urticaria: A Meta-Analysis and Systematic Review. J Allergy Clin Immunol Pract, 6(2), 586-599.

Lammert, J.K., & Robinson, D.M. (1996). Hydroxychloroquine (HCQ) in corticosteroid-dependent chronic urticaria (CDCU). J Allergy Clin Immunol, 97(1), 365.

Ledford, D., Broder, M.S., Antonova, E., Omachi, T.A., Chang, E., & Luskin, A. (2016) Corticosteroid-related toxicity in patients with chronic idiopathic urticarial-chronic spontaneous urticaria. Allergy Asthma Proc, 37(6), 458-465.

Lee, S.J., Ha, E.K., Jee, H.M., Lee, K.S., Lee, S.W., Kim, M.A., … Han, H.Y., (2017). Prevalence and risk factors of urticaria with a focus on chronic urticaria in children. Allergy Asthma Immunol Res, 9(3), 212-219.

Legrain, V., Taieb , A., Sage, T., & Maleville, J. (1990). Urticaria in infants: a study of forty patients. Pediatr Dermatol, 7(2), 101-107.

Leznoff, A., & Sussman, G.L. (1989). Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients. J Allergy Clin Immunol, 84(1), 66-71.

Lieberman, P.L., Umetsu, D.T., Carrigan, G.J., & Rahmaoui, A. (2016). Anaphylactic reactions associated with omalizumab administration: Analysis of a case control study. J Allergy Clin Immunol 138(3), 913-915.

Lindsay, K., Goulding, J., Solomon, M., & Broom, B. (2015). Treating chronic spontaneous urticaria using a brief ‘whole person’ treatment approach: a proof-of-concept study. Clin Transl Allergy, 5, 40.

Liu, T.H., Lin, Y.R., Yang, K.C., Tsai, Y.G., Fu, Y.C., Wu, T.K., & Wu, H.P. (2010). Significant factors associated with severity and outcome of an initial episode of acute urticaria in children. Pediatr Allergy Immunol, 21(7), 1043-1051.

Long, A., Rahmaoui, A., Rothman, K.J., Guinan, E., Eisner, M., Bradley, M.S., …  Szefler, S.J. (2014). Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumab. J Allergy Clin Immunol, 134(3), 560-567.

Lynde, C., Sussman, G., Hébert, J., Gulliver, W., Yang, W.H., Chambenoit, O., … Rihakova, L. (2017).  Omalizumab Retreatment of Patients with Chronic Idiopathic Urticaria/Chronic Spontaneous Urticaria Following Return of Symptoms: Primary Results of the OPTIMA Study EADV. Poster abstract presented at the Clinical Dermatology Conference.

Magen, E., & Mishal, J. (2012). The effect of L-thyroxine treatment on chronic idiopathic urticaria and autoimmune thyroiditis. Int J Dermatol, 51(1), 94-97.

Magerl, M., Pisarevskaja, D., Scheufele, R., Zuberbier, T., & Maurer, M. (2010). Effects of a pseudoallergen-free diet on chronic spontaneous urticaria: a prospective trial. Allergy, 65(1), 78-83.

Malanin, G., & Kalimo, K. (1989). Results of skin testing with food additives and the effect of an elimination diet in chronic and recurrent urticaria and recurrent angioedema. Clin Exp Allergy, 19(5), 539-543.

Mallipeddi, R., & Grattan, C.E. (2007). Lack of response of severe steroid-dependent chronic urticaria to rituximab. Clin Exp Dermatol, 32(3), 333-334.

McGirt, L.Y., Vasagar, K., Gober, L.M., Saini, S.S., & Beck, L.A. (2006). Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine. Arch Dermatol, 142(10),1337-1342.

Metz, M., Ohanyan, T., Church, M.K., & Maurer, M. (2014). Retreatment with omalizumab results in rapid remission in chronic spontaneous urticaria. JAMA Dermatol, 150, 288-290.

Metz, M., Ohanyan, T., Church, M.K., & Maurer, M. (2014). Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis. J Dermatol Sci,  73(1), 57-62.

Mitzel-Kaoukhov, H., Staubach, P., & Muller-Brenne, T. (2010). Effect of high-dose intravenous immunoglobulin treatment in therapy-resistant chronic spontaneous urticaria. Ann Allergy, Asthma & Immunol 104, 253-258.

Mlynek, A., Zalewska-Janowska, A., Martus, P., Staubach, P., Zuberbier, T., Maurer, M. (2008). How to assess disease activity in patients with chronic urticaria? Allergy (6), 777-780.

Monroe, E.W., Cohen, S.H., Kalbfleisch, J., & Schulz, C.I. (1981). Combined H1 and H2 antihistamine therapy in chronic urticaria. Arch Dermatol, 117(7), 404-407. doi:10.1001/archderm.1981.01650070032018

Monroe, E.W., Fox, R.W., Green, A.W., Izuno, C.G.T., Bernstein, D.I., Pleskow, W.W., Wills, I., & Brigante, J.R. (1988). Efficacy and safety of loratadine (10mg once daily) in the management of idiopathic chronic urticaria. J Am Acad Dermatol, 19(1), 138-139.

Mathias, S.D., Crosby, R.D., Zazzali, J.L., Maurer, M., & Saini, S.S. (2012). Evaluating the minimally important difference of the urticaria activity score and other measures of disease activity in patients with chronic idiopathic urticaria. Ann Allergy Asthma Immunol, 108, 20-24.

Maurer, M., Altrichter, S., Bieber, T., (2011). Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase. J Allergy Clin Immunol, 128, 202e205–209e205.

Maurer, M., Rosen, K., Hsieh, H.J., Saini, S., Grattan, C., Gimenez-Arnau, A., … Casale. T., (2013). Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. N Engl J Med; 368(10), 924-935.

Maurer, M., Church, M.K., & Weller, K. (2017). Chronic urticaria in children, still itching for insight. JAMA Derm, 153(12), 1221-1222. http://doi:10.1001/jamadermatol.2017.3183

Monroe, E.W. (1992). Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria and atopic dermatitis. Clin Ther, 14(1), 17-21.

Monroe, E.W. (1992). Relative efficacy and safety of loratadine, hydroxyzine and placebo in chronic idiopathic urticaria. Arzneimittelforschung, 42(9), 1119-1121.

Monroe, E., Finn, A., Patel, P., Guerrero, R., Ratner, P., & Bernstein, D. (2003). Efficacy and safety of desloratadine 5mg once daily in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial. J Am Acad Dermatol, 48(4), 535-541.

Morgan, M., Cooke, A., Rogers, L., Adams-Huet, B., & Khan, D.A. (2014). Double-blind placebo-controlled trial of dapsone in antihistamine refractory chronic idiopathic urticaria. J Allergy Clin Immunol Pract, 2(5), 601-606.

Mortureux, P., Leaute-Labreze, C., Legrain-Lifermann, V., Lamireau, T., Sarlangue, J., & Taieb, A. (1998). Acute urticaria in infancy and early childhood: a prospective study. Arch Dermatol, 134(3), 319-23.

Namazy, J., Cabana, M.D., Scheuerle, A.E., Thorp, J.M., Chen, H., Carrigan, G., Wang, Y., Veith, J., & Andrews, E.B. (2015). The Xolair pregnancy registry (EXPECT): The safety of omalizumab use during pregnancy. J Allergy Clin Immunol, 135(2), 407-412.

Nelson, H.S., Raynolds, R., & Mason J.  (2000). Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria. Ann Allergy Asthma Immunol, 84(5), 517-522.

Netchiporouk, E., Sasseville, D., Moreau, L., Habel, Y., Rahme, E., & Ben-Shoshan, M. (2017). Evaluating comorbidities, natural history, and predictors of early resolution in a cohort of children with chronic urticaria. JAMA Derm, 153(12), 1236-1242.

Nettis, E., Dambra, P., D’Oronzio, L., Loria, M.P., Ferrannini, A., & Tursi, A. (2001). Comparison of montelukast and fexofenadine for chronic idiopathic urticaria.  Arch Dermatol, 137(1) 99-100.

Nettis, E., Pannofino, A., Cavallo, E., Ferrannini, A., & Tursi, A. (2003).  Efficacy of montelukast, in combination with loratadine, in the treatment of delayed pressure urticaria.  J Allergy Clin Immunol, 112(1), 212-213.

Nettis, E., Colanardi, M.C., Paradiso, M.T. & Ferrannini, A.  (2004). Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study. Clin Exp Allergy, 34(9), 1401-1407.

Nettis, E., Clolanardi, M.C., Barra, L., Ferrannini, A., Vacca, A., & Tursi, A. (2006). Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study. Br J Dermatol, 154(3), 533-538.

Noshela Ghazanfar, M., & Thomsen, S.F. (2017). Transient hair loss in patients with chronic spontaneous urticaria treated with omalizumab. Eur Ann Allergy Clin Immunol, 49(6), 284-285.

O'Donnell, B.F., Barr, R.M., Black, A.K., Francis, D.M., Kermani, F., Niimi, N., … Greaves, M.W. (1998). Intravenous immunoglobulin in autoimmune chronic urticaria. Br J Dermatol 138(1), 101-106. Intravenous immunoglobulin in autoimmune chronic urticaria

Ohanyan, T., Schoepke, N., Bolukbasi, B., Metz, M., Hawro, T., Zuberbier, T., … Weller, K. (2017). Responsiveness and minimal important difference of the urticaria control test. J Allergy Clin Immunol, 140(6), 1710-1713.

Orden, R.A., Timble, H., & Saini, S.S. (2014). Efficacy and safety of sulfasalazine in patients with chronic idiopathic urticaria. Ann Allergy Asthma Immunol. 112(1), 64-70.

Ortonne, J.P., Grob, J.J., Auquier, P., & Dreyfus, I. (2007). Efficacy and safety of desloratadine 5mg once daily in the treatment of chronic idiopathic urticaria: a double-blind, placebo-controlled, multicenter trial. Am J Clin Dermatol, 8(1), 37-42.

Pacor, M.L., Di Lorenzo, G., & Corrocher, R.  (2001). Efficacy of leukotriene receptor antagonist in chronic urticaria.  A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic acid.  Clin Exp Allergy, 31(10),1607-1614.

Parslew, R., Pryce D, Ashworth J, & Friedmann PS. (2000). Warfarin treatment of chronic idiopathic urticaria and angio-oedema. Clin Exp Allergy, 30(8), 1161-1165.

Paul, E., & Bodeker, R.H. (1986). Treatment of chronic urticaria with terfenadine and ranitidine.  A randomized double-blind study in 45 patients. Eur J Clin Pharmacol, 31(3), 277-280.

Perez, A., Woods, A., & Grattan, C.E. (2010). Methotrexate: a useful steroid-sparing agent in recalcitrant chronic urticaria. Br J Dermatol, 162(1), 191-194.

Pitt, T., Warrington, R., & Kalicinsky, C. (2010). Adjunctive treatment of chronic idiopathic urticaria and angioedema with sulfasalazine. Allergy Asthma Clin Immunol, 6(1), 25.

Pongonis, R.M., & Fahrenholz, J.M. (2012). Efficacy of Hydroxychloroquine in the Treatment of 19 Patients with Antihistamine-refractory Chronic Urticaria. J Allergy Clin Immunol, 129(2), AB224.

Potter, P.C., Kapp, A., Maurer, M., Guillet, G., Jian, A.M., Hauptmann, P., & Finlay, A.Y. (2009). Comparison of the efficacy of levocetirizine 5mg and desloratadine 5mg in chronic idiopathic urticaria patients. Allergy, 64(4), 596-604.

Powell, R.J., Du Toit, G.L., Siddique, N., Leech, S.C., Dixon, T.A., Clark, A.T., … Huber, P.A. (2007). BSACI guidelines for the management of chronic urticaria and angio-oedema. Clin Exp Allergy, 37(5), 631-650.

Puccetti, A., Bason, C., Simeoni, S., Millo, E., Tinazzi, E., Beri, R., …  Lundari C. (2005). In chronic idiopathic urticaria autoantibodies against Fc epsilonRII/CD23 induce histamine release via eosinophil activation. Clin Exp Allergy, 35(12), 1599-1607.

Raghavendran, R.R., Humphreys, F., & Kaur, M.R. (2014). Successful use of mycophenolate mofetil to treat severe chronic urticaria in a patient intolerant to cyclosporin. Clin Exp Dermatol, 39(1), 68-69.

Rajan, J., Simon, R., & Bosso, J. (2014). Prevalence of sensitivity to food and drug additives in patients with chronic idiopathic urticaria. J Allergy Clin Immunol Pract, 2(2), 168-171.

Reese, I., Zuberbier, T., Bunselmeyer, B., Erdmann, S., Henzgen, M., Fuchs, T., … Werfel T. J. (2009). Diagnostic approach for suspected pseudoallergic reaction to food ingredients. Dtsch Dermatol Ges, 7(1), 70-77.

Reeves, G., Boyle, M., Bonfield, J., Dobson, P., & Loewenthal, M. (2004). Impact of hydroxycholoroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluation. Internal Medicine Journal, 34(4),182-186.

Reider, N., & Egger, C. (2009). Infliximab in the treatment of refractory chronic urticaria. J Am Acad Dermatol, 60(3), AB39.

Reimers, A., Pichler, C., Helbling, A., Pichler, W.J., & Yawalkar, N. (2002). Zafirlukast has no beneficial effects in the treatment of chronic urticaria.  Clin Exp Allergy, 32(12), 1763-1768

Richelson, E. (1979). Tricyclic antidepressants and histamine H1 receptors. Mayo Clin Proc, 54, 669.

Ring, J., Hein, R., Gauger, A., Bronsky, E., & Miller, B. (2001). Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind placebo-controlled study. Int J Dermatol, 40(1), 72-76.

Rorie, A., Goldner, W.S., Lyden, E., & Poole, J.A. (2014). Beneficial role for supplemental vitamin D3 treatment in chronic urticaria: a randomized study. Ann Allergy Asthma Immunol, 112(4), 376-382.

Rudzki, E., Czubalski, K., & Grzywa, Z. (1980). Detection of urticaria with food additives intolerance by means of diet. Dermatologica, 161(1), 57-62.

Rumbyrt, J.S., Katz, J.L., & Schocket AL. (1995). Resolution of chronic urticaria in patients with thyroid autoimmunity. J Allergy Clin Immunol. 96(6 Pt 1), 901-905.

Sabroe, R.A., & Greaves, M.W. (2006). Chronic idiopathic urticaria with functional autoantibodies: 12 years on. Br J Dermatol. 154(5), 813-819.

Sackesen, C., Sekerel, B.E., Orhan, F., Kocabas, C.N., Tuncer, A., & Adalioglu, G. (2004). The etiology of different forms of urticaria in childhood. Pediatr Dermatol, 21(2), 102-108.

Sagi, L., Solomon, M., Baum, S., Lyakhovitsky, A., Trau, H., & Barzilai, A. (2011). Evidence for methotrexate as a useful treatment for steroid-dependent chronic urticaria. Acta Dermato Venereol, 91(3), 303-306.

Sahiner, U.M., Civelek, E., Tuncer, A., Yavuz, S.T., Karabulut, E., Sackesen, C., & Sekerel, B.E. (2011). Chronic urticaria: etiology and natural course in children. Int Arch Allergy Immunol, 156(2), 224-230.

Saini, S.S., & MacGlashan, D. (2002). How IgE upregulates the allergic response. Curr Opin Immunol, 14(6), 694-697.

Saini, S. S., Rosen, K.E., Hsieh, H.J., Wong, D.A., Conner, E., Kaplan, A., Spector, S., & Maurer, M. (2011). A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria. J Allergy Clin Immunol, 128(3), 567-573.

Saini, S.S., Bindslev-Jensen, C., Maurer, M., Grob, J.J., Bulbul Baskan, E., Bradley, M.S., … Rosen, K. (2015). Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H1 antihistamines: a randomized, placebo-controlled study. J Invest Dermatol,135(1), 67-75.

Samarasinghe, V., & Marsland, A.M. (2012). Class action of oral coumarins in the treatment of a patient with chronic spontaneous urticaria and delayed-pressure urticaria. Clin Exp Dermatol, 37(7), 741-743.

Sand, F.L., & Thomsen, S.F. (2013). TNF-Alpha Inhibitors for Chronic Urticaria: Experience in 20 Patients. J Allergy (Cairo), 130905.

Shahar, E., Bergman, R., Guttman-Yassky, E., & Pollack, S. (2006). Treatment of severe chronic idiopathic urticaria with oral mycophenolate mofetil in patients not responding to antihistamines and/or corticosteroids. International Journal of Dermatology, 45, 1224-1227.

Shamsi, Z., & Hindmarch, I. (2000). Sedation and antihistamines: a review of inter-drug differences using proportional impairment ratios.  Human Psychopharmacol, 15(s1), s3-s30.;2-s

Shamsi, Z., & Hindmarch, I. (2008). Sedation and antihistamines: a review of inter-drug differences using proportional impairment ratios.  Human Psychopharmacol, 23(7), 555-570.

Sharma, V.K., Singh, S., Ramam, M., Kumawat, M., & Kumar, R. (2014). A randomized placebo-controlled double-blind pilot study of methotrexate in the treatment of H1 antihistamine-resistant chronic spontaneous urticaria. Indian J Dermatol Venereol Leprol, 80(2), 122-128.

Sharpe, G.R., & Shuster, R. (1993). In dermographic urticaria H2 receptor antagonists have a small but therapeutically irrelevant additional effect compared with H1 antagonists alone. Br J Dermatol, 129(5), 575-579.

Shin, M., & Lee, S., (2017). Prevalence and causes of childhood urticaria. Allergy, Asthma & Immunology Research, 9(3), 189-190.

Siebenhaar, F., Degener. F., Zuberbier. T., MArtus, P. & Maurer, M. (2009). High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled crossover study. J Allergy Clin Immunol, 123(3), 672-679.

Simons, F.E. (2001). Prevention of acute urticaria in young children with atopic dermatitis. J Allergy Clin Immunol, 107(4), 703-706.

Spector, S.L., Shikiar, R., Harding, G., Meeves, S., & Leahy, M.J. (2007). The effect of fexofenadine hydrochloride on productivity and quality of life in patients with chronic idiopathic urticaria. Cutis, 79(2), 157-162.

Staevska, M., Popov, T.A. Kralimarkova, T., Lazatova, C., Kraeva, S., Popova, D., … Church, M.K. (2010). The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria.  J Allergy Clin Immunol, 125(3), 676-682.

Staevska, M., Gugutkova, M., Lazarova, C. Kralimarkova, T., Dimitrov, V., Zuberbier, T., Church, M.K. & Popov, T.A. (2014). Night-time sedating H1-antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial.  Br J Dermatol, 171(1), 148-154.

Staubach, P., Dechene, M., Metz, M., Magerl, M., Siebenhaar, F., Weller, K., … Maurer, M. (2011). High prevalence of mental disorders and emotional distress in patients with chronic spontaneous urticaria. Acta Derm Venereol, 91(5), 557-561.

Staubach, P., Metz, M., Chapman-Rothe, N., Sieder, C., Brautigam, M., Canvin, J., & Maurer, M. (2016). H1-antihistamine-resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial. Allergy, 71(8), 1134-1144.

Sussman, G., Hébert, J., Barron, C., Bian, J., Caron-Guay, R.M., Laflamme, S., & Stern, S. (2014). Real-life experiences with omalizumab for the treatment of chronic urticaria. Ann Allergy Asthma Immunol, 112(2), 170-174.

Tal, Y., Toker, O., Agmon-Levin, N., & Shalit, M. (2014). Azathioprine as a therapeutic alternative for refractory chronic urticaria. Int J Dermatol, 54(3), 367-369.

Tedeschi, A. (2009). Paradoxical exacerbation of chronic urticaria by H1-antihistamines and montelukast. Europ Ann Allergy Clin Immunol, 41(6), 187-189.

Thompson, A.K., Finn, A.F., & Schoenwetter, W.F. (2000). Effect of 60mg twice-daily fexofenadine HCl on quality of life work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria.  J Am Acad Dermatol 43(1 Pt 1), 24-30.

Tondury, B., Muehleisen, B., Ballmer-Weber, B.K., Hofbauer, G., Schmid-Grendelmeier, P., French, L., & Buchi, S. (2011). The Pictorial Representation of Illness and Self Measure (PRISM) instrument reveals a high burden of suffering in patients with chronic urticaria. J Investig Allergol Clin Immunol, 21(2), 93-100.

Toubi E, Kessel A, Avshovich N, Bamber E, Sabo E, Nusem D, Panasoff J. (2004). Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients. Allergy, 59, 869-873.

Vadasz, Z., Tal, Y., Rotem, M., Shichter-Confino, V., Mahlab-Guri, K. Graif, Y., … Sthoeger, Z. (2017). Omalizumab for severe chronic spontaneous urticaria: Real-life experiences of 280 patients. J Allergy Clin Immunol Pract, 5(6), 1743-1745.

Van den Elzen, M., van Os-Medendorp, H., van den Brink, I., van den Hurk, K., Kouznetsova, O.I., … Knulst, A.C. (2017). Effectiveness and safety of antihistamines up to fourfold or higher in treatment of chronic spontaneous urticaria. Clinical and Translational Allergy, 7(4).

Varghese, R., Rajappa, M., Chandrashekar, L., Kattimani, S., Archana, M., Munisamy, M., Revathy, G., & Thappa D. M. (2016) Association among stress, hypocortisolism, systemic inflammation, and disease severity in chronic urticaria. Ann Allergy Asthma Immunol. 116(4), 344-348.

Vena, G., Cassano, N., Colombo, D., Peruzzi, E., & Pigatto, P. (2006). Cyclosporine in chronic idiopathic urticaria: a double-blind, randomised, placebo-controlled trial. J Am Acad Dermatol 55, 705–709.

Verschave, A., Stevens, E., & Degreef, H. (1983). Pseudo-allergen-free diet in chronic urticaria. Dermatologica, 167(5), 256-259.

Wagner, N., Dirk, D., Peveling-Oberhag, A., Reese, I., Rady-Pizarro, U., Mitzel, H., & Staubach, P. (2017). A Popular myth - low-histamine diet improves chronic spontaneous urticaria - fact or fiction? J Eur Acad Dermatol Venereol, 31(4), 650-655.

Wan, K.S. (2009). Efficacy of leukotriene receptor antagonist with an anti-H1 receptor antagonist for treatment of chronic idiopathic urticaria.  J Dermatolog Treat, 20, 194-197.

Wan, K.S., & Chang, (2014). Efficacy of leukotriene receptor antagonist with anti-H1 receptor antagonist plus anti-H2 receptor antagonist for treatment of refractory chronic idiopathic urticaria. J Dermatolog Treat, 25(6), 459-461.

Weller, K.G., Magerl, M., Tohme, N., Martus, P., Krause, K., Metz, M., Staubach, P., & Maurer M. (2013). Development, Validation and Initial Results of the Angioedema Activity Score. Allergy, 68(9),1185-1192.

Weller, K., Groffik, A., Church, M.K., Hawro, T., Krause, K., Metz, M., … Maurer, M. (2014). Development and validation of the Urticaria Control Test: a patient-reported outcome instrument for assessing urticaria control. J Allergy and Clin Immunol, 133(5), 1365-1372.

Wetter, D.A., Davis, M.D., Yiannias, J.A., Gibson, L.E., Dahl, M.V., el-Azhary, R.A., … Pittelkow, M.R. (2005). Effectiveness of intravenous immunoglobulin therapy for skin disease other than toxic epidermal necrolysis: a retrospective review of Mayo Clinic experience. Mayo Clinic Proceedings 80, 41-47.

Wilson, L.H., Eliason, M.J., Leiferman, K.M., Hull, C.M., & Powell, D.L. (2011). Treatment of refractory chronic urticaria with tumor necrosis factor alfa inhibitors. J Am Acad Dermatol. 64(6), 1221-1222.

Zimmerman, A.B., Berger, E.M., Elmariah, S.B., & Soter, N.A. (2012). The use of mycophenolate mofetil for the treatment of autoimmune and chronic idiopathic urticaria: experience in 19 patients. Journal of the American Academy of Dermatology, 66, 767-770.

Zitelli, K.B., & Cordoro, K.M. (2011). Evidence-based evaluation and management of chronic urticaria in children. Pediatr Dermatol, 28(6), 629-639.

Zuberbier, T., Chantraine-Hess, S., Hartmann, K., & Czarnetzki, B.M. (1995). Pseudoallergen-free diet in the treatment of chronic urticaria. A prospective study. Acta Derm Venereol. 75(6), 484-487.

Zuberbier, T., Munzberger, C., Haustein, U., Trippas, E., Burtin, B., Mariz, S.D. & Henz, B.M. (1996). Double-blind crossover study of high-dose cetirizine in cholinergic urticaria. Dermatology, 193(4), 324-327.

Zuberbier, T. (2001). The role of allergens and pseudoallergens in urticaria. J Investig Dermatol Symp Proc, 6(2), 132-134.

Zuberbier, T., Asero, R., Bindslev-Jensen, G., Canonica, G., Church, M.k., Gimenez0Arnau, A., … Maurer, M. (2009). The EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy, 64(10), 1417-1426.

Zuberbier, T., Balke, M., Worm, M., Edenharter, G., & Maurer, M. (2010). Epidemiology of Urticaria; a representive cross-sectional population survey. Clin Exp Dermatol, 35(8), 869-783.

Zuberbier, T., Aberer, W., Asero, R., Abdul Latiff, A.H., Baker, D., Ballmer-Weber, B., … Maurer, M. (2018). The EAACI/GA2LEN/EDF/WAO Guideline for the Definition, Classification, Diagnosis and Management of Urticaria. The 2017 Revision and Update. Allergy 73(7), 1393-1414.

© ASCIA 2021

ASCIA is the peak professional body of clinical immunology/allergy specialists in Australia and New Zealand.

ASCIA resources are based on published literature and expert review, however, they are not intended to replace medical advice. The content of ASCIA resources is not influenced by any commercial organisations.

For more information go to

To donate to immunology/allergy research go to